港股異動 | 短期新低後持續反彈 華虹半導體月內已漲37%
格隆匯9月20日丨華虹半導體(1347.HK)現漲6.05%,報17.88港元,暫成交2.2億港元,最新總市值229.8億港元;該股自8月29日創出短期新低12.66港元后一直處在反彈拉昇模式,至現價已累計漲37%。
消息面上,華虹集團旗下華虹半導體位於無錫12寸生產線(華虹七廠)於9月17日正式投片,首批12寸硅片進入工藝機台,啟動55nm芯片的製造流程。華虹集團董事長表示,經過17個月的緊張奮戰,無錫12寸廠的進度大幅提前,無論是設備安裝或是工藝調試速度都是創紀錄的,充分展現“華虹速度”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.